Most Recent
Court rejects Rio Tinto shareholders’ bid to intervene in Jabiluka mine lease fight
Two firms representing some Rio Tinto shareholders have lost their bid to intervene in Energy Resources' fight to renew its lease for the Jabiluka uranium mine in the Northern Territory.
Reject Shop fights ’18 months of extra liability’ in underpayments class action
The Reject Shop is fighting an underpayments class action’s bid to reformulate its claims, which the discount retailer said could saddle with an extra 18 months of liability.
Sydney light rail class action pulls up to the High Court
The High Court has been asked to revive a class action over Sydney's light rail construction and weigh in on whether litigation funders can claim their commissions as damages.
iSignthis’ John Karantzis could not pay $1.5M penalty, court told
The former CEO of fintech iSignthis would need a loan to pay a $1.5 million penalty sought by the corporate regulator for breaches of directors duties, a court has heard.
Funder seeks $10.6M cut from Mayne Pharma class action settlement
The funder and law firm that ran a shareholder class action against Mayne Pharma are seeking deductions that would leave more than half of a $38 million settlement for group members.
Ditched by Ashurst, Care A2 set to miss own trade mark trial
Care A2 is set to miss the trial in its trade mark fight with rival A2 Milk after the baby formula company was ditched by its lawyers at Ashurst days ago. 
Suppression of Seven reporter’s case a valuable ‘bargaining chip’: judge
Seven has won a suppression order over an ex-Spotlight reporter's claim, with a judge finding that public access to the "colourful and embarrassing" claim could adversely affect mediation.
Isuzu can’t stay Directed Electronics case despite $170M trade secrets win
Vehicle maker Isuzu can't shut down an $18 million suit by car alarm company Directed Electronics over a former employee’s alleged theft of trade secrets.
New battle in Lexapro patent war between Lundbeck, Sandoz
Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.
Ashurst sours on repping Care A2 in trade mark stoush
Bix Six firm Ashurst has dropped Care A2 as a client on the eve of trial in the dairy company's long-running battle to quash rival A2 Milk's trade marks.